PT  - JOURNAL ARTICLE
AU  - Rendani Mbuvha
AU  - Tshilidzi Marwala
TI  - On Data-Driven Management of the COVID-19 Outbreak in South Africa
AID  - 10.1101/2020.04.07.20057133
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.04.07.20057133
4099  - http://medrxiv.org/content/early/2020/04/15/2020.04.07.20057133.short
4100  - http://medrxiv.org/content/early/2020/04/15/2020.04.07.20057133.full
AB  - The rapid spread of the novel coronavirus (SARS-CoV-2) has highlighted the need for the development of rapid mitigating responses under conditions of extreme uncertainty. While numerous works have provided projections of the progression of the pandemic, very little work has been focused on its progression in Africa and South Africa, in particular. In this work, we calibrate the susceptible-infected-recovered (SIR) compartmental model to South African data using initial conditions inferred from progression in Hubei, China and Lombardy, Italy. The results suggest two plausible hypotheses - either the COVID-19 pandemic is still at very early stages of progression in South Africa or a combination of prompt mitigating measures, demographics and social factors have resulted in a slowdown in its spread and severity. We further propose pandemic monitoring and health system capacity metrics for assisting decision-makers in evaluating which of the two hypotheses is most probable.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesPublicly Available data